[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100561491":3},{"organization":4,"outcomesModule":7,"designInfo":26,"detailedDescription":25,"studyPopulation":25,"armGroups":32,"interventions":43,"overallOfficials":53,"centralContacts":57,"locations":63,"responsibleParty":393,"collaborators":25,"id":395,"slug":396,"hasResults":397,"nctId":398,"briefTitle":399,"officialTitle":400,"acronym":401,"eligibilityCriteria":402,"healthyVolunteers":397,"sex":403,"minAge":25,"maxAge":25,"enrollmentInfo":404,"targetDuration":25,"studyType":407,"phases":408,"briefSummary":411,"conditions":412,"keywords":423,"overallStatus":201,"whyStopped":25,"lastUpdateSubmitDate":433,"lastUpdatePostDateStruct":434,"startDateStruct":437,"completionDateStruct":439,"leadSponsor":441,"locationsCount":442},{"fullName":5,"class":6},"RayzeBio, Inc.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":25,"otherOutcomes":25},[9,13,17,20,23],{"measure":10,"description":11,"timeFrame":12},"Dose Escalation","Incidence rate of DLTs during the first 6 weeks of RYZ101 treatment","6 weeks of RYZ101 treatment",{"measure":14,"description":15,"timeFrame":16},"Endocrine Therapy Combination Dose Escalation","Incidence rate of DLTs during the first 6 weeks of study treatment","[Time Frame: 6 weeks of study treatment]",{"measure":14,"description":18,"timeFrame":19},"Incidence and severity of treatment emergent AEs by NCI-CTCAE v5.0","Up to approximately 5 years after the last subject has completed RYZ101 treatment",{"measure":21,"description":22,"timeFrame":19},"Endocrine Therapy Combination Dose Escalation and Expansion","Progression Free Survival, defined as the time between first dose of study treatment and progression or death, as assessed by the investigator per RECIST v1.1 criteria",{"measure":21,"description":24,"timeFrame":19},"Time from the first dose of study treatment to first occurrence of Skeletal Related Events",null,{"allocation":27,"interventionModel":28,"interventionModelDescription":25,"primaryPurpose":29,"observationalModel":25,"timePerspective":25,"maskingInfo":30},"NON_RANDOMIZED","SEQUENTIAL","TREATMENT",{"masking":31,"maskingDescription":25,"whoMasked":25},"NONE",[33,39],{"label":34,"type":35,"description":36,"interventionNames":37},"Monotherapy Dose Escalation","EXPERIMENTAL","Escalating doses of RYZ101 administered intravenously (IV)",[38],"Drug: RYZ101",{"label":21,"type":35,"description":40,"interventionNames":41},"RYZ101 in combination with investigator's choice of standard of care endocrine therapy",[38,42],"Drug: Standard of Care Endocrine Therapy",[44,49],{"type":45,"name":46,"description":47,"armGroupLabels":48,"otherNames":25},"DRUG","RYZ101","Ac-225",[21,34],{"type":45,"name":50,"description":51,"armGroupLabels":52,"otherNames":25},"Standard of Care Endocrine Therapy","Investigator's choice of endocrine therapy, such as, anastrozole, elacestrant, exemestane, fulvestrant, imlunestrant, letrozole, tamoxifen, or vepdegestrant",[21],[54],{"name":55,"affiliation":5,"role":56},"Petrus de Jong, MD, PhD","STUDY_DIRECTOR",[58],{"name":59,"role":60,"phone":61,"phoneExt":25,"email":62},"RayzeBio Clinical Trials","CONTACT","1-619-657-0057","clinicaltrials@rayzebio.com",[64,81,92,102,112,123,134,145,156,167,178,189,200,212,223,234,243,250,261,272,282,293,303,314,325,336,349,360,367,378,388],{"facility":65,"status":66,"city":67,"state":68,"zip":69,"country":70,"countryCode":71,"cosmosGeoPoint":72,"geoPoint":77,"contacts":78},"Research Facility","NOT_YET_RECRUITING","Phoenix","Arizona","85054","United States","US",{"type":73,"coordinates":74},"Point",[75,76],-112.07404,33.44838,{"lat":76,"lon":75},[79],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},"Site Contact",{"facility":65,"status":66,"city":82,"state":83,"zip":84,"country":70,"countryCode":71,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Irvine","California","92618",{"type":73,"coordinates":86},[87,88],-117.82311,33.66946,{"lat":88,"lon":87},[91],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":93,"state":83,"zip":94,"country":70,"countryCode":71,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"San Diego","92093",{"type":73,"coordinates":96},[97,98],-117.16472,32.71571,{"lat":98,"lon":97},[101],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":103,"state":83,"zip":104,"country":70,"countryCode":71,"cosmosGeoPoint":105,"geoPoint":109,"contacts":110},"Santa Monica","90404",{"type":73,"coordinates":106},[107,108],-118.49138,34.01949,{"lat":108,"lon":107},[111],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":113,"state":114,"zip":115,"country":70,"countryCode":71,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Longmont","Colorado","80504",{"type":73,"coordinates":117},[118,119],-105.10193,40.16721,{"lat":119,"lon":118},[122],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":124,"state":125,"zip":126,"country":70,"countryCode":71,"cosmosGeoPoint":127,"geoPoint":131,"contacts":132},"Jacksonville","Florida","32224",{"type":73,"coordinates":128},[129,130],-81.65565,30.33218,{"lat":130,"lon":129},[133],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":135,"state":136,"zip":137,"country":70,"countryCode":71,"cosmosGeoPoint":138,"geoPoint":142,"contacts":143},"Atlanta","Georgia","30322",{"type":73,"coordinates":139},[140,141],-84.38798,33.749,{"lat":141,"lon":140},[144],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":146,"state":147,"zip":148,"country":70,"countryCode":71,"cosmosGeoPoint":149,"geoPoint":153,"contacts":154},"Indianapolis","Indiana","46202",{"type":73,"coordinates":150},[151,152],-86.15804,39.76838,{"lat":152,"lon":151},[155],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":157,"state":158,"zip":159,"country":70,"countryCode":71,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Boston","Massachusetts","02215",{"type":73,"coordinates":161},[162,163],-71.05977,42.35843,{"lat":163,"lon":162},[166],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":168,"state":169,"zip":170,"country":70,"countryCode":71,"cosmosGeoPoint":171,"geoPoint":175,"contacts":176},"Detroit","Michigan","48202",{"type":73,"coordinates":172},[173,174],-83.04575,42.33143,{"lat":174,"lon":173},[177],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":179,"state":180,"zip":181,"country":70,"countryCode":71,"cosmosGeoPoint":182,"geoPoint":186,"contacts":187},"Rochester","Minnesota","55905",{"type":73,"coordinates":183},[184,185],-92.4699,44.02163,{"lat":185,"lon":184},[188],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":190,"state":191,"zip":192,"country":70,"countryCode":71,"cosmosGeoPoint":193,"geoPoint":197,"contacts":198},"St Louis","Missouri","63130",{"type":73,"coordinates":194},[195,196],-90.19789,38.62727,{"lat":196,"lon":195},[199],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":201,"city":202,"state":203,"zip":204,"country":70,"countryCode":71,"cosmosGeoPoint":205,"geoPoint":209,"contacts":210},"RECRUITING","Omaha","Nebraska","68124",{"type":73,"coordinates":206},[207,208],-95.94043,41.25626,{"lat":208,"lon":207},[211],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":213,"state":214,"zip":215,"country":70,"countryCode":71,"cosmosGeoPoint":216,"geoPoint":220,"contacts":221},"Albuquerque","New Mexico","87109",{"type":73,"coordinates":217},[218,219],-106.65114,35.08449,{"lat":219,"lon":218},[222],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":224,"state":225,"zip":226,"country":70,"countryCode":71,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Buffalo","New York","14203",{"type":73,"coordinates":228},[229,230],-78.87837,42.88645,{"lat":230,"lon":229},[233],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":225,"state":225,"zip":235,"country":70,"countryCode":71,"cosmosGeoPoint":236,"geoPoint":240,"contacts":241},"10016",{"type":73,"coordinates":237},[238,239],-74.00597,40.71427,{"lat":239,"lon":238},[242],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":225,"state":225,"zip":244,"country":70,"countryCode":71,"cosmosGeoPoint":245,"geoPoint":247,"contacts":248},"10021",{"type":73,"coordinates":246},[238,239],{"lat":239,"lon":238},[249],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":251,"state":252,"zip":253,"country":70,"countryCode":71,"cosmosGeoPoint":254,"geoPoint":258,"contacts":259},"Cleveland","Ohio","44195",{"type":73,"coordinates":255},[256,257],-81.69541,41.4995,{"lat":257,"lon":256},[260],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":262,"state":263,"zip":264,"country":70,"countryCode":71,"cosmosGeoPoint":265,"geoPoint":269,"contacts":270},"Philadelphia","Pennsylvania","19104",{"type":73,"coordinates":266},[267,268],-75.16362,39.95238,{"lat":268,"lon":267},[271],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":273,"state":263,"zip":274,"country":70,"countryCode":71,"cosmosGeoPoint":275,"geoPoint":279,"contacts":280},"Pittsburgh","15213",{"type":73,"coordinates":276},[277,278],-79.99589,40.44062,{"lat":278,"lon":277},[281],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":283,"state":284,"zip":285,"country":70,"countryCode":71,"cosmosGeoPoint":286,"geoPoint":290,"contacts":291},"Dallas","Texas","75246",{"type":73,"coordinates":287},[288,289],-96.80667,32.78306,{"lat":289,"lon":288},[292],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":294,"state":284,"zip":295,"country":70,"countryCode":71,"cosmosGeoPoint":296,"geoPoint":300,"contacts":301},"Houston","77024",{"type":73,"coordinates":297},[298,299],-95.36327,29.76328,{"lat":299,"lon":298},[302],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":304,"state":305,"zip":306,"country":70,"countryCode":71,"cosmosGeoPoint":307,"geoPoint":311,"contacts":312},"Salt Lake City","Utah","84132",{"type":73,"coordinates":308},[309,310],-111.89105,40.76078,{"lat":310,"lon":309},[313],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":315,"state":316,"zip":317,"country":70,"countryCode":71,"cosmosGeoPoint":318,"geoPoint":322,"contacts":323},"Norfolk","Virginia","23502",{"type":73,"coordinates":319},[320,321],-76.28522,36.84681,{"lat":321,"lon":320},[324],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":326,"state":327,"zip":328,"country":70,"countryCode":71,"cosmosGeoPoint":329,"geoPoint":333,"contacts":334},"Seattle","Washington","98109",{"type":73,"coordinates":330},[331,332],-122.33207,47.60621,{"lat":332,"lon":331},[335],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":337,"state":338,"zip":339,"country":340,"countryCode":341,"cosmosGeoPoint":342,"geoPoint":346,"contacts":347},"Victoria","British Columbia","V8R 6V5","Canada","CA",{"type":73,"coordinates":343},[344,345],-123.35155,48.4359,{"lat":345,"lon":344},[348],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":350,"state":351,"zip":352,"country":340,"countryCode":341,"cosmosGeoPoint":353,"geoPoint":357,"contacts":358},"Toronto","Ontario","M4N 3M5",{"type":73,"coordinates":354},[355,356],-79.39864,43.70643,{"lat":356,"lon":355},[359],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":350,"state":351,"zip":361,"country":340,"countryCode":341,"cosmosGeoPoint":362,"geoPoint":364,"contacts":365},"M5G 2M9",{"type":73,"coordinates":363},[355,356],{"lat":356,"lon":355},[366],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":66,"city":368,"state":369,"zip":370,"country":340,"countryCode":341,"cosmosGeoPoint":371,"geoPoint":375,"contacts":376},"Québec","Quebec","G1S 4L8",{"type":73,"coordinates":372},[373,374],-71.21454,46.81228,{"lat":374,"lon":373},[377],{"name":80,"role":60,"phone":25,"phoneExt":25,"email":25},{"facility":65,"status":379,"city":380,"state":380,"zip":381,"country":382,"countryCode":25,"cosmosGeoPoint":383,"geoPoint":387,"contacts":25},"ACTIVE_NOT_RECRUITING","Seoul","03080","South Korea",{"type":73,"coordinates":384},[385,386],126.9784,37.566,{"lat":386,"lon":385},{"facility":65,"status":379,"city":380,"state":380,"zip":389,"country":382,"countryCode":25,"cosmosGeoPoint":390,"geoPoint":392,"contacts":25},"05505",{"type":73,"coordinates":391},[385,386],{"lat":386,"lon":385},{"type":394,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100561491","phase-1-trial-of-225ac-dotatate-ryz101-in-subjects-with-er-her2-negative-unresectable-or-metastatic-breast-cancer-expressing-sstrs-100561491",false,"NCT06590857","Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.","Phase 1b\u002F2 Open-label Trial of 225Ac-DOTATATE (RYZ101) in Subjects With Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, Locally Advanced and Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors (SSTRs) (TRACY-1).","TRACY-1","Inclusion Criteria\n\nSubjects must meet all the following criteria for enrollment in the study:\n\n* Histologically confirmed, ER+, HER2-negative, locally advanced and unresectable or metastatic breast cancer not amenable to treatment with curative intent.\n* Adequate renal, hematologic, and hepatic function\n* Additional inclusion criteria for Monotherapy arm:\n\n  * Measurable disease with at least 80% SSTR-positive lesions by SSTR-PET imaging\n  * Eastern Cooperative Oncology Group (ECOG) performance status ≤2\n  * Documented radiologic progression after at least 2 and no more than 4 prior chemotherapy or ADC regimens in the metastatic setting\n* Additional inclusion criteria for ET Combination arms:\n\n  * Prior treatment with CDK4\u002F6 inhibitors in combination with endocrine therapy in the advanced or metastatic setting.\n  * Eastern Cooperative Oncology Group (ECOG) performance status ≤1\n  * Bone only or bone dominant disease. At least 1 bone lesion must be SSTR-positive on SSTR-PET imaging. For bone dominant disease, at least 50% of soft tissue measurable lesions must be SSTR-positive on SSTR-PET imaging. At least one bone lesion must be positive on both SSTR-PET and on FDG-PET imaging\n  * Brain metastases are allowed if definitively treated and clinically stable as confirmed by interval imaging\n\nExclusion Criteria\n\nSubjects who meet any of the following criteria will be excluded from the study:\n\n* Prior radiopharmaceutical therapy, including radioembolization.\n* Any toxicities from prior treatments that have not recovered to CTCAE Grade ≤1, except for alopecia.\n* Significant cardiovascular disease\n* Known active uncontrolled or symptomatic central nervous system (CNS) metastases, carcinomatous meningitis, spinal cord compression, or leptomeningeal disease.\n* History of hypersensitivity or allergy to 225Ac, 68Ga, 64Cu, octreotate, or any of the excipients of DOTATATE imaging agents.\n* Prior or concurrent malignancy whose natural history or treatment has the potential to interfere with the study safety or efficacy assessments.\n* Pregnancy or breastfeeding\n* Additional exclusion criteria for ET Combination arms:\n\n  * Presence of liver metastases or symptomatic metastatic visceral disease\n  * Prior PARPi exposure or are candidates for PARPi per local guidelines","ALL",{"count":405,"type":406},64,"ESTIMATED","INTERVENTIONAL",[409,410],"PHASE1","PHASE2","Phase 1b\u002F2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+, HER2-negative unresectable or metastatic breast cancer expressing SSTRs.",[413,414,415,416,417,418,419,420,421,422],"Metastatic Breast Cancer","HER2-negative Breast Cancer","ER+ Breast Cancer","Advanced Breast Cancer","Metastatic Breast Cancer With Bone Involvement","Bone Metastases in Subjects With Advanced Breast Cancer","ER-Positive HER2-Negative Breast Cancer","Estrogen Receptor-positive Breast Cancer","Hormone-sensitive Metastatic Breast Cancer","Hormone-Sensitive Breast Cancer",[424,425,426,427,46,428,429,430,431,432],"Actinium","Alpha-Emitter","SSTR+ MBC","ER+, HER2-, MBC","225Ac","Targeted Radiotherapy","Radiopharmaceutical","SSTR+ ABC","ER+, HER2-, ABC","2026-10-02",{"date":435,"type":436},"2026-10-06","ACTUAL",{"date":438,"type":436},"2024-07-19",{"date":440,"type":406},"2033-11",{"name":5,"class":6},31]